Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Eurofins Publishes Method for Early Detection of Asymptomatic SARS-CoV-2 Virus Spreaders, That Does Not Require Human PCR Clinical Testing


Regulatory News:

Eurofins (Paris:ERF):

Although employees showing COVID-19 symptoms are currently discouraged from going to work, significant workplace COVID-19 outbreaks continue to occur. Virus spread by asymptomatic SARS-CoV-2 infected individuals has been reported to be a significant cause of contamination clusters. Yet, other than PCR testing every employee each day using an invasive nasal or nasopharyngeal swab, few options exist to detect asymptomatic virus spreaders who can contaminate other employees or visitors.

Following an extensive study (1) involving over 6,300 PCR tests at nine office and industrial locations in Europe and North America, Eurofins demonstrated that its Eurofins COVID-19 SentinelTM RT-PCR environmental surfaces tests can contribute to detecting asymptomatic virus spreaders.

Eurofins is launching Eurofins COVID-19 SentinelTM worldwide today as part of its SAFER@WORK™ programme. Through a comprehensive range of testing solutions, including waste water testing, work environment surface testing and worn mask testing, Eurofins COVID-19 Sentinel™ provides an early warning of the presence of SARS-CoV-2 at a given site (e.g. a city, factories, education, government and public service sites, nursing homes), before the virus spreads too broadly. If positive results are found employees present in the rooms tested can be isolated and advised to get tested by clinical RT-PCR.

In response to the COVID-19 pandemic, governments and employers have deployed a set of measures to control the spread of the SARS-CoV-2 virus in workplaces including regular employee testing. Due to barriers to personal testing, such as inconvenience, expense and invasiveness, businesses, education, public and government bodies are looking for non-invasive cost-effective ways for early outbreak detection.

This is why Eurofins developed the Eurofins COVID-19 SentinelTM programme, which is affordable, easily organised and non-invasive. It allows governments and companies to early detect the presence of asymptomatic and pre-symptomatic virus carriers, at times before anyone is aware of the issue, and to assess effectiveness of workplace COVID-19 management plans.

(1) Sentinel Coronavirus Environmental Monitoring Can Contribute to Detecting Asymptomatic SARS-CoV-2 Virus Spreaders and Can Verify Effectiveness of Workplace COVID-19 Controls https://medrxiv.org/cgi/content/short/2020.06.24.20131185v1

The full release can be found at: https://www.eurofins.com/media-centre/press-releases/2020-07-01_2/

For further information, please visit www.eurofins.com

About Eurofins, the global leader in Bioanalysis
With over 47,000 staff across a network of more than 800 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200701005801/en/

Eurofins Scientific SE Stock

€58.80
3.480%
A very strong showing by Eurofins Scientific SE today, with an increase of €1.98 (3.480%) compared to yesterday's price.
The community is currently still undecided about Eurofins Scientific SE with 1 Buy predictions and 0 Sell predictions.
As a result the target price of 60 € shows a slightly positive potential of 2.04% compared to the current price of 58.8 € for Eurofins Scientific SE.
Like: 0
Share
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Legal notice

Comments